Dexcom Dominates 2018 with Phenomenal Earnings
Dexcom, which was also a finalist for MDDIâs Medtech Company of the Year, just reported monumental earnings for 2018 despite growing competition in the continuous glucose monitoring market. âWe achieved [$1.025] billion in revenue in 2018,â Kevin Sayer, president, CEO and chairman of Dexcom said. âThatâs up 43% over what we did in 2017 and thatâs over $300 million in growth in a single year for us. I canât tell you how many things have to go right to make that happen, but a lot of them did.â By all accounts this just shouldnât be the case. The San Diego-based company has faced significant competition and analysts saying the company could be severely impacted by new product launches in the space. In fact, in September of 2017 Dexcom shares plummeted when Abbott Laboratories gained FDA approval for the Freestyle Libre. Dexcomâs uphill battle was said to become even more arduous when its rival, Senseonics, (another finalist for MDDIÂ Medtech company of the year) received approval for a Eversense, an implantable long-term CGM system. Yet the company was able to beat the odds. Sayer said that part of its success came from the earlier-than-expected FDA approval of the G6 CGM System, a device that is interoperable with other automated insulin dosing systems. âOur outlook for 2...
Authors: Khurram A, Abedi D, Abedi M PMID: 32497473 [PubMed - as supplied by publisher]
CONCLUSION: Use of VR facility tours as an alternative to in-person tours of affiliate training facilities during a residency interview day is a viable and innovative option that can save time and money and favorably impact the applicant's impression of the program. More research is necessary to assess whether VR tours can replace in-person tours at the main teaching site, however, while social distancing measures are in place, VR tours may become necessary for programs moving forward. ABBREVIATIONS: Med-Peds: Internal Medicine-Pediatrics; VR: Virtual Reality; AAMC: Association of American Medical Colleges; IRB: Instit...
Authors: Edigin E, Eseaton PO, Shaka H, Ojemolon PE, Asemota IR, Akuna E PMID: 32493181 [PubMed - in process]
Authors: Roberts V, Malone K, Moore P, Russell-Webster T, Caulfield R Abstract Our personal views about the challenges of continuing to deliver peer teaching during a pandemic. We are a group of 4th year medical students who are part of a student society which has delivered structured, highly formulaic peer-led teaching sessions for the past three years. During the COVID-19 pandemic, the reduced access to our normal clinical teaching highlighted the importance of peer-led teaching sessions. We wanted to continue with our peer-taught sessions but knew we would have to devise a new format to make our teaching accessi...
Publication date: Available online 5 June 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Chih-Cheng Lai, Cheng-Yi Wang, Wen-Chien Ko, Po-Ren Hsueh
Publication date: Available online 4 June 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Huei-Hsuan Chiu, Huai-Lei Juan, Po-Liang Lu, Ko Chang
Publication date: Available online 5 June 2020Source: Journal of Microbiological MethodsAuthor(s): Laura Villa, Aurora Torreblanca, Luis Otero, Francisco Carreño, Rainer Campo, María López-Escobar, Fernando Vazquez
Publication date: Available online 5 June 2020Source: Journal of Microbiological MethodsAuthor(s): Dennis L. Welker, Bailey L. Crowley, Justin B. Evans, Martin H. Welker, Jeff R. Broadbent, Robert F. Roberts, David A. Mills
Publication date: Available online 4 June 2020Source: Statistics &Probability LettersAuthor(s): Mohamed Marzougue
Publication date: December 2020Source: Physics of the Dark Universe, Volume 30Author(s): F.D. Villalba, P. Bargueño, A.F. Vargas, E. Contreras
More News: Insulin